Niagen Bioscience said Q2 net sales rose to $29.8 million, driven by Tru Niagen demand and a 23% increase in direct-to-consumer website sales. Net income was $1

Niagen Bioscience said Q2 net sales rose to $29.8 million, driven by Tru Niagen demand and a 23% increase in direct-to-consumer website sales. Net income was $1.0 million and adjusted EBITDA $3.0 million, as NB4168 advanced with EMA orphan status.